Skip to main content

Table 4 Histology information of papers included in systematic review

From: Prediction of resistance to chemotherapy in ovarian cancer: a systematic review

Study Sub-type Stage
Jeong et al. [22] Serous, Endometrioid, Adenocarcinoma I, II, III, IV
Lisowska et al. [23] Serous, Endometrioid, Clear cell, Undifferentiated II, III, IV
Roque et al. [24] Serous, Endometrioid, Clear cell, Undifferentiated, Mixed IIIC, IV
Li et al. [3] Serous, Endometrioid, Clear cell, Mucinous, Transitional II, III, IV
Schwede et al. [25] Serous, Endometrioid, Clear cell, Mucinous, Adenocarcinoma, OSE I, II, III, IV
Verhaak et al. [26] NS II, III, IV
Obermayr et al. [27] Serous, Non-serous II, III, IV
Han et al. [28] Serous, Endometrioid, Clear cell, Mucinous, Mixed, Poorly differentiated II, III, IV
Hsu et al. [29] NS III, IV
Lui et al. [30] Serous II, III, IV
Kang et al. [31] Serous I, II, III, IV
Gillet et al. [32] Serous III, IV
Ferriss et al. [33] Serous, Clear cell, Other III, IV
Brun et al. [34] Serous, Endometrioid, Clear cell, Mucinous, Other III, IV
Skirnisdottir and Seidal [35] Serous, Endometrioid, Clear cell, Mucinous, Anaplastic I, II
Brenne et al. [36] Serous, Endometrioid, Clear cell, Undifferentiated, Mixed II, III, IV
Sabatier et al. [37] Serous, Endometrioid, Clear cell, Mucinous, Undifferentiated, Mixed I, II, III, IV
Gillet et al. [38] Serous III, IV, NS
Chao et al. [39] NS NS
Schlumbrecht et al. [40] Serous III, IV
Glaysher et al. [41] Serous, Endometrioid, Clear cell, Mucinous, Mixed, Poorly differentiated IIIC, IV
Yan et al. [42] Serous, Endometrioid, Clear cell, Mucinous, Transitional II, III, IV
Yoshihara et al. [43] Serous III, IV
Williams et al. [44] Serous, Endometrioid, Undifferentiated III, IV
Denkert et al. [45] Serous, Non-serous, Undifferentiated I, II, III, IV
Matsumura et al. [46] Serous I, II, III, IV
Crijns et al. [47] Serous III, IV
Mendiola et al. [48] Serous, Non-serous III, IV
Gevaert et al. [49] Serous, Endometrioid, Mucinous, Mixed I, III, IV
Bachvarov et al. [50] Serous, Endometrioid, Clear cell II, III, IV
Netinatsunthorn et al. [51] Serous III, IV
De Smet et al. [52] Serous, Endometrioid, Mucinous, Mixed I, III, IV
Helleman et al. [53] Serous, Endometrioid, Clear cell, Mucinous, Mixed, Poorly differentiated I/II, III/IV
Spentzos et al. [54] Serous, Endometrioid, Clear cell, Mixed I, II, III, IV
Jazaeri et al. [55] Serous, Endometrioid, Clear cell, Mixed, Undifferentiated, Carcinoma II, III, IV
Raspollini et al. [56] Serous IIIC
Hartmann et al. [57] Serous, Endometrioid, Mixed II, III, IV
Spentzos et al. [58] Serous, Endometrioid, Clear cell, Mixed I, II, III, IV
Selvanayagam et al. [59] Serous, Endometrioid, Clear cell, Undifferentiated III, IV
Iba et al. [60] Serous, Endometrioid, Clear cell, Mixed I, II, III, IV
Kamazawa et al. [61] Serous, Endometrioid, Clear cell III, IV
Vogt et al. [62] NS NS
  1. Entries in bold indicate that the study data set was comprised of at least 80% this type. NS: Not Specified.